Showing results (71-80 of 386) with videos related to

Sort By:
Pageof 39
Cancer Immunology Research|November 22, 2015
Radiologic Heterogeneity in Responses to Anti-PD-1/PD-L1 Therapy in Metastatic Renal Cell CarcinomaGuillermo de Velasco, Katherine M Krajewski, Laurence Albiges, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 18, 2014
Metastatic mucosal melanoma: imaging patterns of metastasis and recurrenceKevin O'Regan, Micheál Breen, Nikhil Ramaiya, et al.
Cellular and Molecular Bioengineering|December 19, 2022
Chemotherapy Dose Shapes the Expression of Immune-Interacting Markers on Cancer CellsAlexander J Najibi, Kerry Larkin, Zhaoqianqi Feng, et al.
Blood|August 30, 2002
Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREXAngela M Krackhardt, Mathias Witzens, Sabine Harig, et al.
Cancer Immunology Research|May 7, 2015
Single Institution Experience of Ipilimumab 3 mg/kg with Sargramostim (GM-CSF) in Metastatic MelanomaJason J Luke, Hilary Donahue, Mizuki Nishino, et al.
Oncoimmunology|June 15, 2018
Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanomaXinqi Wu, Anita Giobbie-Hurder, Erin M Connolly, et al.
JAMA Oncology|October 4, 2017
Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysisRomualdo Barroso-Sousa, William T Barry, Ana C Garrido-Castro, et al.
Clinical and Translational Gastroenterology|April 7, 2026
Immune Checkpoint Inhibitor Esophagitis: Clinical and Endoscopic Presentation, Treatment Outcomes, and ComplicationsMatthew J Townsend, Afeerah Mumtaz, Jordan S Sack, et al.
Immunotherapy|June 13, 2022
Multiple high-grade and rare immune-related adverse events in a colon cancer patient with genomic and cytokine profilingKevin Tyan, Osama Abu-Shawer, Joanna Baginska, et al.
Cancer Treatment Reviews|July 26, 2014
Durable benefit and the potential for long-term survival with immunotherapy in advanced melanomaDavid McDermott, Celeste Lebbé, F Stephen Hodi, et al.
Pageof 39